Permira, the global private equity firm, announced today that a company backed by the Permira funds has successfully completed the acquisition of Lyophilization Services of New England, Inc (“LSNE”), a leading contract development and manufacturing organization for the pharmaceutical and medical device markets.
The Permira funds’ investment will support the company’s many growth opportunities, including expanding the company’s capacity to better serve its growing customer base and address commercial stage opportunities, extending its capabilities in manufacturing and development services, and pursuing selective acquisitions.
Matt Halvorsen, LSNE Founder and Chief Executive Officer, will continue to lead the company in his current role and maintain a significant equity stake in the company going forward. Additionally, Claes Glassell, the former CEO of CMC Biologics and a 30-year pharmaceutical industry veteran, has joined as Chairman of the Board of LSNE.
Click the PDF icon to download the full release.